| Item Type | Name |
|
Concept
|
Neoplastic Cells, Circulating
|
|
Academic Article
|
Circulating tumor cells as prognostic marker in metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells revisited.
|
|
Academic Article
|
Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.
|
|
Academic Article
|
Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
|
|
Academic Article
|
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
|
|
Academic Article
|
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells.
|
|
Academic Article
|
Molecular mechanisms of metastasis in breast cancer--clinical applications.
|
|
Academic Article
|
Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case series.
|
|
Academic Article
|
Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy.
|
|
Academic Article
|
Circulating tumor cells in breast cancer: a tool whose time has come of age.
|
|
Academic Article
|
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.
|
|
Academic Article
|
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.
|
|
Academic Article
|
Circulating tumor cells and PET.
|
|
Academic Article
|
CTCs in metastatic breast cancer.
|
|
Academic Article
|
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer.
|
|
Academic Article
|
Considerations in the development of circulating tumor cell technology for clinical use.
|
|
Academic Article
|
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
|
|
Academic Article
|
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.
|
|
Academic Article
|
Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis.
|
|
Academic Article
|
The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy response.
|
|
Academic Article
|
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
|
|
Academic Article
|
The "microscopic" revolution in breast carcinoma.
|
|
Academic Article
|
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.
|
|
Academic Article
|
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?
|
|
Academic Article
|
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
|
|
Academic Article
|
Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden.
|
|
Academic Article
|
Integrating circulating tumor cell assays into the management of breast cancer.
|
|
Academic Article
|
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.
|
|
Academic Article
|
Circulating tumor cells in breast cancer: fiction or reality?
|
|
Academic Article
|
Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
|
|
Academic Article
|
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
|
|
Academic Article
|
Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.
|
|
Academic Article
|
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
|
|
Academic Article
|
Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors.
|
|
Academic Article
|
The biological information obtainable from circulating tumor cells.
|
|
Academic Article
|
The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.
|
|
Academic Article
|
Circulating giant macrophages as a potential biomarker of solid tumors.
|
|
Academic Article
|
Circulating tumour cells: telling the truth about metastasis.
|
|
Academic Article
|
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.
|
|
Academic Article
|
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
|
|
Academic Article
|
Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(?) CTC test.
|
|
Academic Article
|
Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patients.
|
|
Academic Article
|
Circulating tumor cells in newly diagnosed inflammatory breast cancer.
|
|
Academic Article
|
Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?
|
|
Academic Article
|
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care Utility.
|
|
Academic Article
|
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.
|
|
Academic Article
|
Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
|
|
Academic Article
|
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.
|
|
Academic Article
|
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.
|
|
Academic Article
|
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
|
|
Academic Article
|
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas.
|
|
Academic Article
|
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
|
|
Academic Article
|
Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients.
|
|
Academic Article
|
Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers.
|
|
Academic Article
|
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
|
|
Academic Article
|
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.
|
|
Academic Article
|
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.
|
|
Academic Article
|
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.
|
|
Academic Article
|
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
|
|
Academic Article
|
Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells.
|
|
Academic Article
|
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
|
|
Academic Article
|
Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor Cells.
|
|
Academic Article
|
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize.
|
|
Academic Article
|
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer.
|
|
Academic Article
|
Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
|
|
Academic Article
|
Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays.
|
|
Academic Article
|
Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy.
|
|
Academic Article
|
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
|
|
Academic Article
|
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.
|
|
Academic Article
|
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.
|
|
Academic Article
|
Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.
|
|
Academic Article
|
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
|
|
Academic Article
|
Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.
|
|
Academic Article
|
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.
|
|
Academic Article
|
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
|
|
Academic Article
|
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
|
|
Academic Article
|
Minimal Residual Disease in Patients With Nonmetastatic Triple-Negative Breast Cancer: Positive, Negative, or a More Complex Issue?
|
|
Academic Article
|
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
|
|
Academic Article
|
Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics.
|
|
Academic Article
|
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer.
|
|
Academic Article
|
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.
|
|
Academic Article
|
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer.
|
|
Academic Article
|
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer.
|
|
Academic Article
|
EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer.
|
|
Academic Article
|
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.
|
|
Academic Article
|
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
|
|
Academic Article
|
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior.
|
|
Academic Article
|
Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'?
|
|
Academic Article
|
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome.
|
|
Academic Article
|
Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer.
|
|
Academic Article
|
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix? PC1 System.
|
|
Academic Article
|
Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis.
|
|
Academic Article
|
Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer.
|
|
Academic Article
|
Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer.
|
|
Academic Article
|
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.
|
|
Academic Article
|
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer.
|
|
Academic Article
|
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine.
|
|
Academic Article
|
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.
|
|
Academic Article
|
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer.
|
|
Academic Article
|
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling.
|